What's in Bosnalijek D.D's pipeline?

Bosnalijek D.D has 3 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Bosnalijek D.D's portfolio?

Top competitors by shared drug class: Pfizer, Ain Shams Maternity Hospital, Atlantic Health System, Aligarh Muslim University, Amorphical Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bosnalijek-d-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Bosnalijek D.D — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bosnalijek D.D pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Lysobact Complete Sprey	Lysobact Complete Sprey	phase 3	Antibiotic	Infectious Diseases
Pharyngal® Oromucosal Spray	Pharyngal® Oromucosal Spray	phase 3	Local anesthetic	Pain management
Tantum Verde® Spray	Tantum Verde® Spray	phase 3	Antacid	Gastrointestinal

Therapeutic area mix

Gastrointestinal · 1
Infectious Diseases · 1
Pain management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 2 shared drug classes
Ain Shams Maternity Hospital · 1 shared drug class
Atlantic Health System · 1 shared drug class
Aligarh Muslim University · 1 shared drug class
Amorphical Ltd. · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Ain Shams University · 1 shared drug class
Achaogen, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Bosnalijek D.D:

Cite this brief

Drug Landscape (2026). Bosnalijek D.D — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bosnalijek-d-d. Accessed 2026-05-16.